Insider trades

Thomas Leggett, CFO of Stoke Therapeutics STOK, has filed 0 purchases and 5 sales on the open market. Over the past 12 months that comes to a net sale of $147.1K. The latest trade was on 03/18.

Thomas Leggett

CFO
First filing
24/05/17
Trades
12 trades
Buys / sales
0 / 5
12-month net buying
−$147.1K
Last trade
03/18

Trading activity

Transactions

Trade type
STOK
Open-market sale03/17–03/1803/194,578 sh5 trades$32.14avg.$147,141.89−31.0%